Click for best price
Dendritic Cell Cancer Vaccine Market Size, Share 2023
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.
This report aims to provide a comprehensive presentation of the global market for Dendritic Cell Cancer Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dendritic Cell Cancer Vaccine. This report contains market size and forecasts of Dendritic Cell Cancer Vaccine in global, including the following market information:
Global Dendritic Cell Cancer Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dendritic Cell Cancer Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Dendritic Cell Cancer Vaccine companies in 2022 (%)
The global Dendritic Cell Cancer Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
CreaVax Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dendritic Cell Cancer Vaccine include Activarti, Argos Therapeutics, SOTIO (Acquired by PPF Group), Bellicum Pharmaceuticals, JW CreaGene, DanDrit, DCPrime, Elios Therapeutics and ImmunoCellular Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dendritic Cell Cancer Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Cancer Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, by Type, 2022 (%)
CreaVax
Sipuleucel-T (Provenge)
Others
Global Dendritic Cell Cancer Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, by Application, 2022 (%)
Pediatrics
Adults
Global Dendritic Cell Cancer Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Cancer Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dendritic Cell Cancer Vaccine revenues share in global market, 2022 (%)
Key companies Dendritic Cell Cancer Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies Dendritic Cell Cancer Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Activarti
Argos Therapeutics
SOTIO (Acquired by PPF Group)
Bellicum Pharmaceuticals
JW CreaGene
DanDrit
DCPrime
Elios Therapeutics
ImmunoCellular Therapeutics
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Immutep Limited
Dendreon Corporation
Oncobiomed
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dendritic Cell Cancer Vaccine, market overview.
Chapter 2: Global Dendritic Cell Cancer Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Dendritic Cell Cancer Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dendritic Cell Cancer Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dendritic Cell Cancer Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Dendritic Cell Cancer Vaccine Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dendritic Cell Cancer Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dendritic Cell Cancer Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dendritic Cell Cancer Vaccine Overall Market Size
2.1 Global Dendritic Cell Cancer Vaccine Market Size: 2022 VS 2029
2.2 Global Dendritic Cell Cancer Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dendritic Cell Cancer Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Dendritic Cell Cancer Vaccine Players in Global Market
3.2 Top Global Dendritic Cell Cancer Vaccine Companies Ranked by Revenue
3.3 Global Dendritic Cell Cancer Vaccine Revenue by Companies
3.4 Global Dendritic Cell Cancer Vaccine Sales by Companies
3.5 Global Dendritic Cell Cancer Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dendritic Cell Cancer Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dendritic Cell Cancer Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Dendritic Cell Cancer Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dendritic Cell Cancer Vaccine Market Size Markets, 2022 & 2029
4.1.2 CreaVax
4.1.3 Sipuleucel-T (Provenge)
4.1.4 Others
4.2 By Type - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
4.2.1 By Type - Global Dendritic Cell Cancer Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Dendritic Cell Cancer Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
4.3.1 By Type - Global Dendritic Cell Cancer Vaccine Sales, 2018-2023
4.3.2 By Type - Global Dendritic Cell Cancer Vaccine Sales, 2024-2029
4.3.3 By Type - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dendritic Cell Cancer Vaccine Market Size, 2022 & 2029
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
5.2.1 By Application - Global Dendritic Cell Cancer Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Dendritic Cell Cancer Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
5.3.1 By Application - Global Dendritic Cell Cancer Vaccine Sales, 2018-2023
5.3.2 By Application - Global Dendritic Cell Cancer Vaccine Sales, 2024-2029
5.3.3 By Application - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Dendritic Cell Cancer Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
6.2.1 By Region - Global Dendritic Cell Cancer Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Dendritic Cell Cancer Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
6.3.1 By Region - Global Dendritic Cell Cancer Vaccine Sales, 2018-2023
6.3.2 By Region - Global Dendritic Cell Cancer Vaccine Sales, 2024-2029
6.3.3 By Region - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Dendritic Cell Cancer Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Dendritic Cell Cancer Vaccine Sales, 2018-2029
6.4.3 US Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.4.4 Canada Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.4.5 Mexico Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Dendritic Cell Cancer Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Dendritic Cell Cancer Vaccine Sales, 2018-2029
6.5.3 Germany Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.5.4 France Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.5.5 U.K. Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.5.6 Italy Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.5.7 Russia Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.5.9 Benelux Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Dendritic Cell Cancer Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Dendritic Cell Cancer Vaccine Sales, 2018-2029
6.6.3 China Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.6.4 Japan Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.6.5 South Korea Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.6.7 India Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Dendritic Cell Cancer Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Dendritic Cell Cancer Vaccine Sales, 2018-2029
6.7.3 Brazil Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.7.4 Argentina Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, 2018-2029
6.8.3 Turkey Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.8.4 Israel Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Dendritic Cell Cancer Vaccine Market Size, 2018-2029
6.8.6 UAE Dendritic Cell Cancer Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Activarti
7.1.1 Activarti Company Summary
7.1.2 Activarti Business Overview
7.1.3 Activarti Dendritic Cell Cancer Vaccine Major Product Offerings
7.1.4 Activarti Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Activarti Key News & Latest Developments
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Company Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Argos Therapeutics Key News & Latest Developments
7.3 SOTIO (Acquired by PPF Group)
7.3.1 SOTIO (Acquired by PPF Group) Company Summary
7.3.2 SOTIO (Acquired by PPF Group) Business Overview
7.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Major Product Offerings
7.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 SOTIO (Acquired by PPF Group) Key News & Latest Developments
7.4 Bellicum Pharmaceuticals
7.4.1 Bellicum Pharmaceuticals Company Summary
7.4.2 Bellicum Pharmaceuticals Business Overview
7.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Major Product Offerings
7.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.5 JW CreaGene
7.5.1 JW CreaGene Company Summary
7.5.2 JW CreaGene Business Overview
7.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Major Product Offerings
7.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 JW CreaGene Key News & Latest Developments
7.6 DanDrit
7.6.1 DanDrit Company Summary
7.6.2 DanDrit Business Overview
7.6.3 DanDrit Dendritic Cell Cancer Vaccine Major Product Offerings
7.6.4 DanDrit Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 DanDrit Key News & Latest Developments
7.7 DCPrime
7.7.1 DCPrime Company Summary
7.7.2 DCPrime Business Overview
7.7.3 DCPrime Dendritic Cell Cancer Vaccine Major Product Offerings
7.7.4 DCPrime Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 DCPrime Key News & Latest Developments
7.8 Elios Therapeutics
7.8.1 Elios Therapeutics Company Summary
7.8.2 Elios Therapeutics Business Overview
7.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Elios Therapeutics Key News & Latest Developments
7.9 ImmunoCellular Therapeutics
7.9.1 ImmunoCellular Therapeutics Company Summary
7.9.2 ImmunoCellular Therapeutics Business Overview
7.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 ImmunoCellular Therapeutics Key News & Latest Developments
7.10 Kiromic
7.10.1 Kiromic Company Summary
7.10.2 Kiromic Business Overview
7.10.3 Kiromic Dendritic Cell Cancer Vaccine Major Product Offerings
7.10.4 Kiromic Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Kiromic Key News & Latest Developments
7.11 Medigene
7.11.1 Medigene Company Summary
7.11.2 Medigene Dendritic Cell Cancer Vaccine Business Overview
7.11.3 Medigene Dendritic Cell Cancer Vaccine Major Product Offerings
7.11.4 Medigene Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Medigene Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Dendritic Cell Cancer Vaccine Business Overview
7.12.3 Merck Dendritic Cell Cancer Vaccine Major Product Offerings
7.12.4 Merck Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 Northwest Biotherapeutics
7.13.1 Northwest Biotherapeutics Company Summary
7.13.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Business Overview
7.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.13.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Northwest Biotherapeutics Key News & Latest Developments
7.14 Immutep Limited
7.14.1 Immutep Limited Company Summary
7.14.2 Immutep Limited Business Overview
7.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Major Product Offerings
7.14.4 Immutep Limited Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Immutep Limited Key News & Latest Developments
7.15 Dendreon Corporation
7.15.1 Dendreon Corporation Company Summary
7.15.2 Dendreon Corporation Business Overview
7.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Major Product Offerings
7.15.4 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Dendreon Corporation Key News & Latest Developments
7.16 Oncobiomed
7.16.1 Oncobiomed Company Summary
7.16.2 Oncobiomed Business Overview
7.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Major Product Offerings
7.16.4 Oncobiomed Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Oncobiomed Key News & Latest Developments
8 Global Dendritic Cell Cancer Vaccine Production Capacity, Analysis
8.1 Global Dendritic Cell Cancer Vaccine Production Capacity, 2018-2029
8.2 Dendritic Cell Cancer Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dendritic Cell Cancer Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dendritic Cell Cancer Vaccine Supply Chain Analysis
10.1 Dendritic Cell Cancer Vaccine Industry Value Chain
10.2 Dendritic Cell Cancer Vaccine Upstream Market
10.3 Dendritic Cell Cancer Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dendritic Cell Cancer Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Dendritic Cell Cancer Vaccine in Global Market
Table 2. Top Dendritic Cell Cancer Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dendritic Cell Cancer Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dendritic Cell Cancer Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Dendritic Cell Cancer Vaccine Sales by Companies, (Units), 2018-2023
Table 6. Global Dendritic Cell Cancer Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dendritic Cell Cancer Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Dendritic Cell Cancer Vaccine Product Type
Table 9. List of Global Tier 1 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dendritic Cell Cancer Vaccine Sales (Units), 2018-2023
Table 15. By Type - Global Dendritic Cell Cancer Vaccine Sales (Units), 2024-2029
Table 16. By Application ? Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dendritic Cell Cancer Vaccine Sales (Units), 2018-2023
Table 20. By Application - Global Dendritic Cell Cancer Vaccine Sales (Units), 2024-2029
Table 21. By Region ? Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dendritic Cell Cancer Vaccine Sales (Units), 2018-2023
Table 25. By Region - Global Dendritic Cell Cancer Vaccine Sales (Units), 2024-2029
Table 26. By Country - North America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dendritic Cell Cancer Vaccine Sales, (Units), 2018-2023
Table 29. By Country - North America Dendritic Cell Cancer Vaccine Sales, (Units), 2024-2029
Table 30. By Country - Europe Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dendritic Cell Cancer Vaccine Sales, (Units), 2018-2023
Table 33. By Country - Europe Dendritic Cell Cancer Vaccine Sales, (Units), 2024-2029
Table 34. By Region - Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dendritic Cell Cancer Vaccine Sales, (Units), 2018-2023
Table 37. By Region - Asia Dendritic Cell Cancer Vaccine Sales, (Units), 2024-2029
Table 38. By Country - South America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dendritic Cell Cancer Vaccine Sales, (Units), 2018-2023
Table 41. By Country - South America Dendritic Cell Cancer Vaccine Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, (Units), 2024-2029
Table 46. Activarti Company Summary
Table 47. Activarti Dendritic Cell Cancer Vaccine Product Offerings
Table 48. Activarti Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Activarti Key News & Latest Developments
Table 50. Argos Therapeutics Company Summary
Table 51. Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 52. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Argos Therapeutics Key News & Latest Developments
Table 54. SOTIO (Acquired by PPF Group) Company Summary
Table 55. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Offerings
Table 56. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. SOTIO (Acquired by PPF Group) Key News & Latest Developments
Table 58. Bellicum Pharmaceuticals Company Summary
Table 59. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offerings
Table 60. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bellicum Pharmaceuticals Key News & Latest Developments
Table 62. JW CreaGene Company Summary
Table 63. JW CreaGene Dendritic Cell Cancer Vaccine Product Offerings
Table 64. JW CreaGene Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. JW CreaGene Key News & Latest Developments
Table 66. DanDrit Company Summary
Table 67. DanDrit Dendritic Cell Cancer Vaccine Product Offerings
Table 68. DanDrit Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. DanDrit Key News & Latest Developments
Table 70. DCPrime Company Summary
Table 71. DCPrime Dendritic Cell Cancer Vaccine Product Offerings
Table 72. DCPrime Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. DCPrime Key News & Latest Developments
Table 74. Elios Therapeutics Company Summary
Table 75. Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 76. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Elios Therapeutics Key News & Latest Developments
Table 78. ImmunoCellular Therapeutics Company Summary
Table 79. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 80. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. ImmunoCellular Therapeutics Key News & Latest Developments
Table 82. Kiromic Company Summary
Table 83. Kiromic Dendritic Cell Cancer Vaccine Product Offerings
Table 84. Kiromic Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Kiromic Key News & Latest Developments
Table 86. Medigene Company Summary
Table 87. Medigene Dendritic Cell Cancer Vaccine Product Offerings
Table 88. Medigene Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Medigene Key News & Latest Developments
Table 90. Merck Company Summary
Table 91. Merck Dendritic Cell Cancer Vaccine Product Offerings
Table 92. Merck Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Merck Key News & Latest Developments
Table 94. Northwest Biotherapeutics Company Summary
Table 95. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 96. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Northwest Biotherapeutics Key News & Latest Developments
Table 98. Immutep Limited Company Summary
Table 99. Immutep Limited Dendritic Cell Cancer Vaccine Product Offerings
Table 100. Immutep Limited Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Immutep Limited Key News & Latest Developments
Table 102. Dendreon Corporation Company Summary
Table 103. Dendreon Corporation Dendritic Cell Cancer Vaccine Product Offerings
Table 104. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Dendreon Corporation Key News & Latest Developments
Table 106. Oncobiomed Company Summary
Table 107. Oncobiomed Dendritic Cell Cancer Vaccine Product Offerings
Table 108. Oncobiomed Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Oncobiomed Key News & Latest Developments
Table 110. Dendritic Cell Cancer Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 111. Global Dendritic Cell Cancer Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Dendritic Cell Cancer Vaccine Production by Region, 2018-2023 (Units)
Table 113. Global Dendritic Cell Cancer Vaccine Production by Region, 2024-2029 (Units)
Table 114. Dendritic Cell Cancer Vaccine Market Opportunities & Trends in Global Market
Table 115. Dendritic Cell Cancer Vaccine Market Drivers in Global Market
Table 116. Dendritic Cell Cancer Vaccine Market Restraints in Global Market
Table 117. Dendritic Cell Cancer Vaccine Raw Materials
Table 118. Dendritic Cell Cancer Vaccine Raw Materials Suppliers in Global Market
Table 119. Typical Dendritic Cell Cancer Vaccine Downstream
Table 120. Dendritic Cell Cancer Vaccine Downstream Clients in Global Market
Table 121. Dendritic Cell Cancer Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dendritic Cell Cancer Vaccine Segment by Type in 2022
Figure 2. Dendritic Cell Cancer Vaccine Segment by Application in 2022
Figure 3. Global Dendritic Cell Cancer Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dendritic Cell Cancer Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dendritic Cell Cancer Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Dendritic Cell Cancer Vaccine Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Revenue in 2022
Figure 9. By Type - Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Dendritic Cell Cancer Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Dendritic Cell Cancer Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 23. US Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 37. China Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dendritic Cell Cancer Vaccine Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Dendritic Cell Cancer Vaccine by Region, 2022 VS 2029
Figure 54. Dendritic Cell Cancer Vaccine Industry Value Chain
Figure 55. Marketing Channels
